Greenwich LifeSciences (GLSI) Stock Forecast, Price & News

Greenwich LifeSciences (NASDAQ:GLSI) Frequently Asked Questions

Is Greenwich LifeSciences a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Greenwich LifeSciences in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Greenwich LifeSciences stock.
View analyst ratings for Greenwich LifeSciences or view top-rated stocks.

What price target have analysts set for GLSI?

1 brokerages have issued 12 month price objectives for Greenwich LifeSciences' shares. Their forecasts range from $78.00 to $78.00. On average, they anticipate Greenwich LifeSciences' share price to reach $78.00 in the next year. This suggests a possible upside of 800.7% from the stock's current price.
View analysts' price targets for Greenwich LifeSciences or view top-rated stocks among Wall Street analysts.

Who are Greenwich LifeSciences' key executives?

Greenwich LifeSciences' management team includes the following people:

• Mr. Snehal S. Patel, CEO, CFO & Director (Age 58, Pay $925k) (LinkedIn Profile)
• Mr. Eric Rothe, Founder & Independent Director (Age 46)
• Dr. Frank Joseph Daugherty M.D., Chief Medical Officer & Director (Age 71) (LinkedIn Profile)
• Dr. Jaye L. Thompson Ph.D., VP of Clinical & Regulatory Affairs (Age 56)
• Dr. Christine T. Fischette Ph.D., VP of Bus. Devel. (Age 71)

Who are some of Greenwich LifeSciences' key competitors?

Some companies that are related to Greenwich LifeSciences include Imago BioSciences (IMGO), Centessa Pharmaceuticals (CNTA), Cara Therapeutics (CARA), Vera Therapeutics (VERA), Kinnate Biopharma (KNTE), Karyopharm Therapeutics (KPTI), Nurix Therapeutics (NRIX), Day One Biopharmaceuticals (DAWN), Y-mAbs Therapeutics (YMAB), Albireo Pharma (ALBO), Janux Therapeutics (JANX), Adicet Bio (ACET), Affimed (AFMD), Nkarta (NKTX) and IDEAYA Biosciences (IDYA).
View all of GLSI's competitors.

When did Greenwich LifeSciences IPO?

(GLSI) raised $7 million in an initial public offering on Friday, September 25th 2020. The company issued 1,300,000 shares at a price of $5.75 per share. Aegis Capital served as the underwriter for the IPO.

What is Greenwich LifeSciences' stock symbol?

Greenwich LifeSciences trades on the NASDAQ under the ticker symbol "GLSI."

Who are Greenwich LifeSciences' major shareholders?

Greenwich LifeSciences' stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (2.90%), BlackRock Inc. (1.82%), State Street Corp (0.51%), Northern Trust Corp (0.27%) and Nisa Investment Advisors LLC (0.06%). Company insiders that own Greenwich LifeSciences stock include David Mcwilliams, Frank Joseph Daugherty, Jaye Thompson, Kenneth Hallock and Snehal Patel.
View institutional ownership trends for Greenwich LifeSciences.

Which institutional investors are selling Greenwich LifeSciences stock?

GLSI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., and Northern Trust Corp.
View insider buying and selling activity for Greenwich LifeSciences or view top insider-selling stocks.

Which institutional investors are buying Greenwich LifeSciences stock?

GLSI stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Nisa Investment Advisors LLC, and State Street Corp. Company insiders that have bought Greenwich LifeSciences stock in the last two years include David Mcwilliams, Frank Joseph Daugherty, Jaye Thompson, Kenneth Hallock, and Snehal Patel.
View insider buying and selling activity for Greenwich LifeSciences or or view top insider-buying stocks.

How do I buy shares of Greenwich LifeSciences?

Shares of GLSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Greenwich LifeSciences' stock price today?

One share of GLSI stock can currently be purchased for approximately $8.66.

How much money does Greenwich LifeSciences make?

Greenwich LifeSciences has a market capitalization of $112.15 million.

How many employees does Greenwich LifeSciences have?

Greenwich LifeSciences employs 3 workers across the globe.

What is Greenwich LifeSciences' official website?

The official website for Greenwich LifeSciences is www.greenwichlifesciences.com.

How can I contact Greenwich LifeSciences?

The company can be reached via phone at 832-819-3232 or via email at [email protected].